TriMas Co. (NASDAQ:TRS) Director Buys $10,430,673.96 in Stock

TriMas Co. (NASDAQ:TRSGet Free Report) Director Shawn Sedaghat purchased 410,172 shares of the company’s stock in a transaction on Wednesday, May 21st. The stock was acquired at an average price of $25.43 per share, with a total value of $10,430,673.96. Following the completion of the purchase, the director now directly owns 1,810,821 shares in the company, valued at $46,049,178.03. This trade represents a 29.28% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Shawn Sedaghat also recently made the following trade(s):

  • On Thursday, May 22nd, Shawn Sedaghat purchased 72,937 shares of TriMas stock. The stock was acquired at an average price of $26.16 per share, with a total value of $1,908,031.92.
  • On Tuesday, May 20th, Shawn Sedaghat purchased 104,957 shares of TriMas stock. The stock was acquired at an average price of $25.70 per share, with a total value of $2,697,394.90.
  • On Monday, May 19th, Shawn Sedaghat purchased 254,400 shares of TriMas stock. The stock was acquired at an average price of $25.39 per share, with a total value of $6,459,216.00.
  • On Wednesday, April 30th, Shawn Sedaghat purchased 123,388 shares of TriMas stock. The stock was acquired at an average price of $23.83 per share, with a total value of $2,940,336.04.
  • On Monday, March 10th, Shawn Sedaghat purchased 554,149 shares of TriMas stock. The stock was acquired at an average price of $24.07 per share, with a total value of $13,338,366.43.
  • On Friday, March 7th, Shawn Sedaghat bought 249,597 shares of TriMas stock. The shares were purchased at an average price of $23.83 per share, with a total value of $5,947,896.51.

TriMas Stock Down 2.5%

NASDAQ TRS opened at $25.42 on Friday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.44 and a current ratio of 2.83. The company has a market capitalization of $1.03 billion, a P/E ratio of 39.72 and a beta of 0.58. TriMas Co. has a one year low of $19.33 and a one year high of $28.51. The stock has a 50 day moving average price of $23.01 and a 200-day moving average price of $24.07.

TriMas (NASDAQ:TRSGet Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $0.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.03. The company had revenue of $241.67 million during the quarter, compared to the consensus estimate of $235.41 million. TriMas had a return on equity of 9.21% and a net margin of 2.93%. TriMas’s revenue was up 6.4% on a year-over-year basis. During the same period last year, the company earned $0.37 earnings per share. As a group, equities analysts predict that TriMas Co. will post 1.69 EPS for the current fiscal year.

TriMas Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, May 13th. Investors of record on Tuesday, May 6th were given a $0.04 dividend. The ex-dividend date was Tuesday, May 6th. This represents a $0.16 dividend on an annualized basis and a yield of 0.63%. TriMas’s dividend payout ratio is presently 20.78%.

Institutional Trading of TriMas

A number of institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its position in TriMas by 2.2% in the fourth quarter. Vanguard Group Inc. now owns 3,895,946 shares of the industrial products company’s stock worth $95,801,000 after buying an additional 82,068 shares during the last quarter. Bank of America Corp DE lifted its position in TriMas by 127.3% in the fourth quarter. Bank of America Corp DE now owns 3,513,638 shares of the industrial products company’s stock worth $86,400,000 after buying an additional 1,967,738 shares during the last quarter. Pzena Investment Management LLC lifted its position in TriMas by 0.7% in the first quarter. Pzena Investment Management LLC now owns 2,135,554 shares of the industrial products company’s stock worth $50,036,000 after buying an additional 14,942 shares during the last quarter. Bellecapital International Ltd. bought a new stake in TriMas in the fourth quarter worth $29,160,000. Finally, Medina Value Partners LLC lifted its position in TriMas by 2.9% in the fourth quarter. Medina Value Partners LLC now owns 1,034,882 shares of the industrial products company’s stock worth $25,448,000 after buying an additional 28,851 shares during the last quarter. 99.42% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Wall Street Zen downgraded TriMas from a “buy” rating to a “hold” rating in a research report on Saturday. BWS Financial reiterated a “buy” rating and set a $40.00 target price on shares of TriMas in a research report on Wednesday, April 30th.

Get Our Latest Research Report on TRS

About TriMas

(Get Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Recommended Stories

Insider Buying and Selling by Quarter for TriMas (NASDAQ:TRS)

Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.